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I.  INTRODUCTION 	  
[1] Some of the most dynamic areas of robotics research and 
development today are healthcare applications.1 Robot-assisted surgery,2 	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1 See generally Healthcare Robotics: 2014, ROBOTICS BUS. REV. (July 14, 2014), 
http://www.roboticsbusinessreview.com/research/report/healthcare_robotics_2014, 
archived at perma.cc/2XSV-JMXJ (“To support, enhance, and mitigate the healthcare 
burdens, our healthcare system is witnessing robotic medical technology entering hospital 
surgical suites, in-patient rooms, in-home patient care, and uses with emergency services 
and vehicles.”). 
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robotic nurses, 3  in-home rehabilitation, 4  and eldercare robots 5  are all 
demonstrating rapidly iterating innovation. Rising healthcare labor costs 
and an aging population will increase demand for these human surrogates 
and enhancements. However, like many emerging technologies, robots are 
difficult to place within existing regulatory frameworks. For example, the 
federal Food, Drug, and Cosmetic Act (FD&C Act) seeks to ensure that 
medical devices (few of which are consumer devices) are safe, the HIPAA 
Privacy and Security Rules apply to data collected by health care 
providers (but not most consumer-facing hardware or software 
developers), and state licensing statutes oversee the conduct of doctors and 
nurses who, heretofore, have all been human beings.  
 
[2] This paper will focus on the issues of patient and user safety, 
security, and privacy, and specifically the effect of medical device 
regulation and data protection laws on robots in healthcare. First, it will 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
2 See generally John Markoff, New Research Center Aims to Develop Second Generation 
of Surgical Robots, N.Y. TIMES (Oct. 23, 2014), 
http://www.nytimes.com/2014/10/23/science/new-research-center-aims-to-develop-
second-generation-of-surgical-robots.html?_r=0, archived at https://perma.cc/VT6V-
L7KY (describing the University of California, Berkeley’s new “research center intended 
to help develop medical robots that can perform low-level and repetitive surgical tasks, 
freeing doctors to concentrate on the most challenging and complex aspects of the 
operations they perform”). 
 
3 See generally Robotic Nurse Assistant, HEALTHCARE ROBOTICS GA. INST. OF TECH. 
http://www.hsi.gatech.edu/hrl/project_nurse.shtml, archived at https://perma.cc/S3W2-
23TG (last visited Nov. 24, 2015) (describing the ways in which “robotics can play a role 
in assisting nurses to complete their daily tasks in order to provide better healthcare,” and 
the University’s Healthcare Robotics Lab’s “Direct Physical Interface” project). 
 
4 See generally Rehabilitation Robotics, CHARM LAB, 
http://charm.stanford.edu/Main/RehabilitationRobotics, archived at 
https://perma.cc/MHY5-A4FF (last visited Nov. 24, 2015) (describing rehabilitation 
robotics projects, including “Robotic Manipulation for Reaching” and “HAPI Bands: 
Haptic Augmented Posture Interface”). 
 
5 See generally Will Knight, Your Retirement May Include a Robot Helper, MIT TECH. 
REV. (Oct. 27, 2014), http://www.technologyreview.com/news/531941/your-retirement-
may-include-a-robot-helper/, archived at https://perma.cc/QJ36-ZQ8N (stating “robotics 
companies are eyeing elder care as a huge potential market”).  
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examine the demand for robots in healthcare and assess the benefits that 
robots can provide. Second, it will look at the types of robots currently 
being used in healthcare, anticipate future innovation, and identify the key 
characteristics of these robots that will present regulatory issues. Third, it 
will examine the current regulatory framework within which these robots 
will operate, focusing on medical device regulation and data protection 
laws. 
 
[3] A serious definitional problem confronts any such mapping of 
emerging technologies to existing regulatory systems. This is certainly the 
case with healthcare robots. For example, many interesting legal or policy 
issues arise surrounding the use of teleoperated robotics systems (e.g. 
surgical robots directly controlled by a surgeon). However, this paper 
focuses on existing and emerging robots with far greater levels of 
autonomy.6 Such autonomy includes the supervisory control paradigm, in 
which certain functions are automated with a human supervising the 
system, all the way to fully autonomous robots.7 Similarly, health care 
environments that are reliant on or dominated by all-purpose “healthcare 
companions” and robotic “doctors,” utilizing artificial intelligence, will 
raise fascinating questions. However, these technologies will not be 
available for purchase or be deployed in our hospitals any time soon.  
Further, when they are, they will not have come out of nowhere, catching 
patients or consumers by surprise. Rather, this paper concentrates on near 
term issues. Even absent the stuff of science fiction, the first several 
generations of healthcare robots will themselves pose challenging issues. 
Robots in healthcare will be an evolution in the coming decades, and there 
are basic questions that need to be addressed in this nearer future in order 
to ensure that robots are able to maintain sustainable innovation with the 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
6 Whereas most medical devices, and many currently deployed robots, represent 
automatic systems that act according to a preprogrammed script with defined entry and 
exit conditions for a task, this paper will focus on the unique implications of autonomous 
robots, which independently and dynamically determine if, when, and how to execute a 
task.  
 
7 By autonomous, we mean robots that have the ability to reason and take actions on their 
own without explicit approval from a human. 
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confidence of providers, patients, consumers, and investors. Only through 
such responsible design, deployment, and use will robots’ potential be 
maximized in healthcare. 
 
[4] Because we are likely to see health-related robots appearing in 
both conventional healthcare and consumer spaces, there will be 
regulatory disruption and the opportunity for regulatory arbitrage.8 We 
argue the regulation of both spaces must change. In order to maximize 
robots’ potential and minimize risks to users, regulation will need to move 
towards some form of premarket review of robot “safety.” Such review, 
likely by the Food and Drug Administration (FDA), should include broad 
considerations of potential harms, including security. In the data 
protection sphere, existing sector-based limitations that lead to gaps 
between, for example, Federal Trade Commission (FTC) and Department 
of Health and Human Services’ Office for Civil Rights (HHS-OCR) 
oversight, should be eliminated so that both patient and consumer privacy 
and security interests can be better protected. A foundational regulatory 
framework for both medical devices and consumers that is attuned to 
safety, security, and privacy will help foster innovation and confidence in 
robotics and ensure that we maximize robotic potential in healthcare. 
 
II.  ROBOTS IN HEALTHCARE: DEMAND AND BENEFITS 	  
[5] Much of the demand for robots in healthcare stems from their 
ability to perform tasks that human beings either cannot do, do not wish to 
do, or cannot do as well or as efficiently. Efficiency is critical in both the 
hospital and home healthcare settings, as evidenced by strained hospital 
staffs9 and a shortage of home caregivers.10 An aging population logically 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
8 See infra note 48 and accompanying text.  
 
9 See, e.g., Christopher J. Gearon, Staffing the Hospital of Tomorrow, U.S. NEWS & 
WORLD REP. (Oct. 16, 2013, 12:15 PM), http://health.usnews.com/health-news/hospital-
of-tomorrow/articles/2013/10/16/staffing-the-hospital-of-tomorrow, archived at 
https://perma.cc/G63A-5J8F (“Hospital staffing changes are driven by an aging 
population, a physician workforce shortage and health care reform.”). 
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increases this demand. Worldwide, people are simply living longer. 
According to the United Nations, the world population over the age of 60 
has tripled over the last 50 years, and is expected to triple again to 2 
billion by 2050.11 This trend will greatly impact the home care sector, as 
evidence demonstrates a desire among older populations to stay in the 
home, as opposed to living in a care facility.12 But professional home care 
workers are in such high demand that their lack of qualifications and 
training are often overlooked.13 Effectively designed robots could help 
meet this demand in a safer and more responsible, sustainable manner.  
 
[6] Robots might also help meet demand for services created by the 
overall rising cost of healthcare, particularly its labor costs. Although there 
is some debate surrounding the long-term cost effectiveness of robots, the 
ability of robots to expand healthcare services outside the traditional 
healthcare setting could relieve current strains on hospital resources.  In 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
10 See Barbara Peters Smith, Finding skilled elder home care workers not easy, HERALD-
TRIB. (May 26, 2013, 3:30 PM), 
http://www.heraldtribune.com/article/20130526/ARTICLE/130529745/-
1/sports?Title=NEW-Finding-skilled-elder-home-care-employees-not-easy, archived at 
https://perma.cc/2B22-2YYZ [hereinafter Finding skilled elder home care]. 
 
11 See U.N. DEP’T OF ECON. & SOC. AFFAIRS, POPULATION DIV., WORLD POPULATION 
AGEING 1950-2050, at 11, U.N. Doc. ST/ESA/SER.A/207, U.N. Sales No. E.02.XIII.3 
(2002), 
https://web.archive.org/web/20150122071228/http://www.un.org/esa/population/publicati
ons/worldageing19502050/pdf/80chapterii.pdf, archived at https://perma.cc/474X-
VTEA. 
 
12 See Barbara Peters Smith, Nation at crossroads in home care for elders, HERALD-TRIB. 
(May 25, 2013, 10:48 PM), 
http://www.heraldtribune.com/article/20130525/ARTICLE/130529761, archived at 
https://perma.cc/ECU9-ZQCC (describing how most older Americans prefer care in their 
own home to institutionalization) [hereinafter Nation at crossroads]. 
 
13 See Finding skilled elder home care, supra note 10 (describing “a fast-growing 
industry where many workers lack the training and skills needed for safe and reliable 
caregiving” and the fact that “the rising demand for home health care has induced more 
people to obtain certified nurse assistant licenses when they are not suited for the work”). 
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addition, homecare is often less expensive than institutionalization.14 
Many believe that robots are preferable to humans in the home setting,15 
not only for their ability to outwork humans physically,16 but also for their 
potential to provide emotional care and support.17 
 
[7] Finally, the industry trend toward personalized healthcare may 
increase demand for robots.18  Robots may be especially helpful for 
patients requiring rehabilitation19  and for those with special needs. 20 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
14 See Nation at crossroads, supra note 12.  
 
15 See Jason Maderer, How Would You Like Your Assistant- Human or Robotic?, GA. 
TECH. NEWS CENTER (Apr. 29, 2013), http://www.news.gatech.edu/2013/04/29/how-
would-you-your-assistant-human-or-robotic, archived at https://perma.cc/C3D7-JW9E. 
 
16 See e.g., New SF Hospital Feels Like the Jetsons, YOUTH HEALTH (Feb. 1, 2015), 
http://www.youthhealthmag.com/articles/8602/20150201/ucsf-mission-bay-hospital-
robots-in-healthcare-robots-in-hospitals-aethon-robots-aethon.htm, archived at 
https://perma.cc/25GY-R3DK (“Each of the robots can also carry as much as 1,000 
pounds of objects and travel for twelve miles a day.”). 
 
17 See Barbara Peters Smith, Robots and More: Technology and the Future of Elder Care, 
HERALD-TRIB. (May 27, 2013), 
http://www.heraldtribune.com/article/20130527/ARTICLE/130529720?p=5&tc=pg, 
archived at https://perma.cc/5GQY-7SW6 (“[Robots] can in fact be of considerable 
assistance in providing physical aid, and might not be that bad as an emotional 
companion. People, with their imaginations, can create all kinds of characteristics that we 
might not believe possible.”); see e.g. PARO THERAPEUTIC ROBOT, www.parorobots.com 
(last visited Jan. 29, 2016).  
 
18 See Notice of Updates to the National Robotics Initiative, Notice no. NOT-EB-14-008, 
NAT’L INST. OF HEALTH (Oct. 23, 2014), http://grants.nih.gov/grants/guide/notice-
files/NOT-EB-14-008.html, archived at https://perma.cc/2W2X-65Y6 (“Affordable and 
accessible robotic technology can facilitate wellness and personalized healthcare.”). 
 
19 See A Research Roadmap for Medical and Healthcare Robotics, STAN. UNIV. (2008), 
http://bdml.stanford.edu/twiki/pub/Haptics/HapticsLiterature/CCC-medical-healthcare-
v7.pdf, archived at https://perma.cc/H85L-S7JW (“Socially assistive robotics focuses on 
using sensory data from wearable sensors, cameras, or other means of perceiving the 
user’s activity in order to provide the robot with information about the user that allows 
the machine to appropriately encourage and motivate sustained recovery exercises.”). 
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Research in this area is underway, and will likely increase in the coming 
years.21 
 
[8] In order to realize and sustain these benefits, robots must be 
designed and deployed in the healthcare setting in a manner that 
maximizes their safety, security, and sensitivity to user privacy.  Such 
deployment must include taking into consideration potential security and 
privacy issues22 that could, if overlooked, manifest themselves in ways 
that harm patients and consumers, diminish the trust of key stakeholders of 
robots in healthcare, and stifle long-term innovation.  Understanding these 
risks requires an appreciation for the ways in which data are, and will be, 
utilized by robots in healthcare, and the regulatory landscape within which 
robots will operate. 
 
[9] As Frank Tobe has said, “[t]he many stakeholders in robotic 
healthcare (family members and caregivers, healthcare providers, 
technology providers, aging or disabled individuals) all have similar goals:  
To provide independence, preserve dignity, empower those with special 
needs and provide peace of mind to all of the stakeholders.”23 Ensuring 
that safety, security, and privacy are promoted during the development, 
deployment, and use of robots in healthcare will help guarantee the long-
term ability of robots to help stakeholders meet these goals. 
 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
20 See id. (“Socially assistive robots have been shown to have promise as therapeutic tool 
for children, the elderly, stroke patients, and other special-needs populations requiring 
personalized care.”). 
 
21 See e.g., MIT Scientists Launch Personalized Robot Project, PHYS.ORG (Apr. 3, 
2012), http://phys.org/news/2012-04-scientists-personalized-robot.html, archived at 
https://perma.cc/5W3X-435L (“This project aims to dramatically reduce the development 
time for a variety of useful robots, opening the doors to potential applications in 
manufacturing, education, personalized healthcare, and even disaster relief.”). 
 
22 See infra Parts III, IV. 
 
23 Frank Tobe, Where Are the Elder Care Robots?, IEEE SPECTRUM (Nov. 12, 2012, 
4:25 PM), http://spectrum.ieee.org/automaton/robotics/home-robots/where-are-the-
eldercare-robots, archived at https://perma.cc/WCW3-6UM9. 
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III.  ROBOT TYPES AND CHARACTERISTICS 	  
[10] To meet demand and seize the potential benefits of robots in 
healthcare, research is being conducted at companies and universities, and 
through national and international public and private initiatives. In the 
United States, the National Science Foundation (NSF) partnered with 
other organizations in a National Robotics Initiative with National 
Institutes of Health (NIH) participation in its Computer Science and 
Robotics Research program devoted to medical robots.24 Last year, the 
European Union launched SPARC, the world’s largest civilian robotics 
program, which has a focus on healthcare.25  But probably the most 
significant public and private investment in healthcare-specific robotics is 
taking place in Japan.26 Given its own baby boom generation with growing 
needs, demand has sparked several independent research initiatives and 
plans for government projects.27 
 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
24 See Michael S. Young, Artificial Intelligence, Telemedicine, and Robotics in 
Healthcare, 6 SCITECH LAWYER 14 (Spring 2010), 
http://www.fellerssnider.com/userfiles/file/MYoung%20AI%20article.pdf, archived at 
https://perma.cc/WZA8-23RU. 
 
25 See About SPARC, SPARC ROBOTICS, http://sparc-robotics.eu/, archived at 
https://perma.cc/5KP8-23ZE (last visited Jan. 29, 2016). 
 
26 See Tim Maverick, Japan’s Tech Solution for Its Aging Population, WALL ST. DAILY 
(July 11, 2015), http://www.wallstreetdaily.com/2015/07/11/japan-healthcare-robots/, 
archived at https://perma.cc/J2EN-7B5B. 
 
27 See Christian Crisotomo, Robots: Japan’s Future Elderly Care Workers, VR WORLD 
(Jan. 22, 2015), http://www.vrworld.com/2015/01/22/robots-japans-future-elderly-care-
workers/, archived at https://perma.cc/J4FM-DLHE (“Japan’s elderly healthcare industry 
can be considered as a very important testbed that would help develop better robots in the 
future. . . . [R]obots may soon be Japan’s future elderly care workers. Japan is the country 
with the highest number of elderly citizens. According to reports published a few years 
ago, it is estimated that at least more than 20% of the population in Japan comprise of 
elderly people aged 65 and above. Thus, there is more focus on elderly care in Japan than 
any other country.  In fact so much, that the country is in constant need for caregivers and 
nurses who would look after their dankai no sedai (Japanese baby boomer) population.”). 
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[11] These initiatives have led to the deployment of a variety of robots 
in healthcare, and more are being designed every day. Identifying the 
types and characteristics of different robots in healthcare will help identify 
the regulatory issues that must be confronted. 
 
[12] Perhaps the most frequently discussed robots in healthcare today 
are “so-called surgical robots,” such as the daVinci Surgical System.28  
These systems present a number of interesting legal issues, especially 
involving product and practice liability.29 However, because doctors, at 
least for now, directly control surgical robots, these robots more closely 
resemble traditional medical devices than the sort of autonomous robots 
that will present unique safety, security, and privacy challenges. This 
could change, however, as surgical robots become increasingly 
autonomous.30 
 
[13] Another emerging robot in the hospital setting is what can be 
described as a “routine task” robot, such as the kind recently introduced in 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
28 Berkeley’s Autonomous Surgical Robotic System, MEDGADGET (Oct. 30, 2014), 
http://www.medgadget.com/2014/10/berkeleys-autonomous-surgical-robotic-
system.html, archived at https://perma.cc/JR5N-V5RY. 
 
29 See, e.g., Joe Carlson & Jaimy Lee, Medical boon or bust? Suits raise allegations of 
defects in da Vinci robot, MOD. HEALTHCARE (May 25, 2013), 
http://www.modernhealthcare.com/article/20130525/MAGAZINE/305259977, archived 
at https://perma.cc/2Y7K-ZGZU; see also Sulbha Sankhla, Robotic Surgery and Law in 
USA—a Critique, at 36–40 (June 1, 2013) (Unpublished Critique for LLM in IP Law and 
Policy, University of Washington), 
http://papers.ssrn.com/sol3/papers.cfm?abstract_id=2425046, archived at 
https://perma.cc/RZ5V-DVSP. 
 
30 See Berkeley’s Autonomous Surgical Robotic System, supra note 28 (“While so-called 
surgical robots have been around for a few years now, they are really not robots at all, but 
rather remotely controlled machines that faithfully execute the commands of their 
masters. For robots to be real robots, they have to be autonomous and able to do tasks 
without much operator input. . . . Researchers at UC Berkeley have been working on 
getting a da Vinci surgical system to be smart enough to do some basic tasks on its 
own.”). 
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a University of California San Francisco (UCSF) hospital.31 The UCSF 
robots were deployed in order to “bring meals and medications to patients, 
transfer lab specimens, and carry linens,” and each can “carry up to 1,000 
pounds and travel twelve miles a day.”32 These essentially custodial robots 
are more autonomous and mobile, but not necessarily anthropomorphic or 
social. Their appeal lies in the fact that they can perform simple, routine 
tasks in order to free up human staff to perform the more “core functions” 
of healthcare.33 Although these robots’ tasks are “routine” now, they have 
the potential to begin taking on medical or caregiving tasks as their 
development advances. 
 
[14] The most significant regulatory issues, though, could arise with 
“personal care” robots in the hospital and home healthcare settings. By 
their very nature, these robots will operate in increasingly autonomous and 
life-like ways, eventually performing actual care on patients and 
consumers. Someday, they may work alongside—or even replace—nurses, 
home care workers, and even doctors. There is already an emergence of 
rehabilitation robots in hospitals and general personal “assistant” or “care” 
robots in the home. As these robots begin to take on more medical tasks 
and caregiving functions, their potential to benefit society will depend in 
part on responsible design and use that accounts for safety, security, and 
privacy. Issues will arise in these areas as a result of several key 
characteristics of robots in healthcare. 
 
[15] First, robots in the healthcare setting are performing an increasing 
number of functions, which will only continue to grow in number.34 Such 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
31 See New SF Hospital Feels Like the Jetsons, supra note 16. 
 
32 Id. 
 
33 See id. 
 
34 See Jessica Cocco, Note, Smart Home Technology for the Elderly and the Need for 
Regulation, 6 J. ENVTL. & PUB. HEALTH L. 85, 92–95 (2011), 
http://pjephl.law.pitt.edu/ojs/index.php/pjephl/article/view/56/44, archived at 
https://perma.cc/WRR3-4NGV (explaining the difference between passive and active-
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functions include providing medication assistance, helping move patients, 
and communicating with doctors. As robots in healthcare access or 
connect with other devices, their functionality increases in complexity and 
variety.35 With advancements in artificial intelligence and the ability to 
share and access vast amounts of data in the cloud, robots may someday 
be relied upon to make actual on-the-spot medical decisions, and be able 
to act on those decisions, such as administering medications. As a result, 
robots in healthcare are becoming increasingly autonomous in terms of 
both mobility and decision-making abilities. 
 
[16] In addition, the data collection, processing, storing, and use of 
information by robots in healthcare are all vast compared to that of other 
medical devices. 36  When considering how best to handle data, it is 
important to consider both data that are necessary for the robot to function 
properly (including navigation, object recognition, etc.), and data that are 
desirable and will help robots maximize opportunities and fulfill specific 
medical and healthcare goals of doctors, patients, and consumers. 
 
[17] Shifting from a general consumer setting to a healthcare-specific 
context, either in the hospital or the home, both especially unstructured 
environments, will increase the importance of a robot knowing and 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
intervention devices, and noting that robots resemble all three versions of active-
intervention devices—sensors, reminder systems, and medication assistance). 
 
35 See ERICA PALMERINI ET AL., ROBOLAW:  GUIDELINES ON REGULATING ROBOTICS 175 
(Sept. 22, 2014), 
http://www.robolaw.eu/RoboLaw_files/documents/robolaw_d6.2_guidelinesregulatingro
botics_20140922.pdf, archived at https://perma.cc/783Z-YQ2U (explaining that personal 
care robots “will not be developed by implementing a single functioning (as in the case of 
robotic prosthesis)” and “could mutate function and form”) [hereinafter ROBOLAW]. 
 
36 See generally Christopher Prentice, Technology in Healthcare Makes Evidence-based 
Medicine more Achievable with Automated Data Collection, CIOREVIEW, 
http://robotics.cioreview.com/cxoinsight/new-technology-in-healthcare-makes-
evidencebased-medicine-more-achievable-with-automated-data-collection-nid-6019-cid-
75.html, archived at https://perma.cc/8ZKX-KFAZ (last visited Feb. 2, 2016). 
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possibly sharing the location of medication, objects, and people37—all 
especially critical to a robot’s ability to effectively aid in treatment and 
care. 
 
[18] In its 2014 Guidelines on Regulating Robotics, European research 
group RoboLaw acknowledged that the needs of the elderly have created 
demand for complex services that require networked robots, or “a group of 
autonomous mobile systems that exploit wireless communications with 
each other or with the environment and living systems in order to fulfill 
complex tasks.”38 Many of these features will necessitate complex data 
collection and use practices, which, given the uniqueness of robots and 
sensitivity of health-related information, will raise significant security and 
privacy issues. 
 
IV.  THE DISTINCTIVE FEATURES OF ROBOT DATA COLLECTION AND 
USE 	  
[19] In light of their potential benefits, the complexity of robot data 
collection and use practices raise potential security and privacy issues in 
the healthcare setting.39 The future healthcare robot will be able to monitor 
patients closely at all hours (one of their advantages over humans), and 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
37 See Evan Ackerman, Hoaloha Robotics Developing Socially Assistive Hardware 
Platform, IEEE SPECTRUM (Sept. 4, 2013, 2:36 PM), 
http://spectrum.ieee.org/automaton/robotics/home-robots/hoaloha-robotics-developing-
socially-assistive-hardware-platform, archived at https://perma.cc/B9MJ-4YFL (quoting 
Hoaloha Robotics: “Our robot has the benefit of knowing if a user is nearby and if the 
user is currently looking at the robot and for how long. It also tracks when the last 
conversation was, what it was about, and the history of other conversations with this user 
at this time of day.”). 
 
38 ROBOLAW, supra note 35, at 169.  
 
39 See, e.g., id. at 177 (Policy considerations include the fact that “[d]iagnostic, 
monitoring tools or any other device can be placed on board robots, thus gathering data 
on their environment and people.” Further, “[t]hese data could be shared with other 
platforms even on a global basis . . . Thus, legal questions about data security and privacy 
issues need to be addressed.”). 
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report information back to various health information technologies, other 
robots, and even human providers. Such data collection and use will 
increase in volume and complexity in both the hospital and home settings 
as medical devices begin taking on more autonomous functions and as 
personal consumer robots perform more healthcare tasks. These practices 
are distinguishable from other data actors because of the necessary access 
such robots will need to existing user information, the generation of new 
information, and the unprecedented resulting overall information they will 
possess about users.40 Robots, even more than other technologies, will 
depend on connecting to other devices, including wearables and personal 
cell phones, for optimal information access and performance.41 This is 
especially true in the healthcare context, where wearables and mobile 
applications increasingly collect health and wellness related information 
about users.42 At the 2015 Consumer Electronics Show, Adam Thierer 
noted that “we can expect [personal care robots] to be fully networked, 
data-collecting machines that will know as much about us as any human 
caregiver, [and] possibly much more.”43 
 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
40 See, e.g., id. at 189 (explaining that privacy risks with personal care robots “would be 
greater than the limitation of privacy caused by the ‘Granny Cam’ monitoring systems 
adopted in nursing homes” because “[t]he personal data are likely to be particularly 
sensitive as they pertain to the health of individuals, their life choices, political, 
philosophical and religious beliefs, sexual habits, etc. and this could eventually lead to a 
real ‘death of privacy’”).  
 
41 See id. at 169 (“In such systems, sensor networks and other intelligent agents, for 
example wearable and personal devices, extend the sensing range of the robots and 
improve their planning and cooperation capabilities.”). 
 
42 See Harry Rhodes, Accessing and Using Data from Wearable Fitness Devices, 85 J. 
AHIMA 48 (Sept. 2014), 
http://library.ahima.org/xpedio/groups/public/documents/ahima/bok1_050743.hcsp?dDoc
Name= bok1_050743, archived at https://perma.cc/K629-UX3A. 
 
43 Adam Thierer, CES 2015 Dispatch: Challenges Multiply for Privacy Professionals, 
Part Two, PRIVACY PERSPECTIVES (Jan. 14, 2015), https://iapp.org/news/a/ces-2015-
dispatch-challenges-multiply-for-privacy-professionals-part-two/, archived at 
https://perma.cc/2U6B-GKCV (emphasis removed). 
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[20] Robots in healthcare will need to generate, use, and sometimes 
share a tremendous amount of data to function in the chaotic and 
unstructured hospital and home environments. Eventual ubiquity of robots 
in healthcare may lead to the use of cost effective “cloud robotics,” 
outsourcing much of the robots’ processing to remote servers where they 
can learn from the experiences of other robots and draw from databases 
for tasks such as object recognition.44 The consumer setting may prove to 
be a catalyst for the development of cloud robotics and a consumer market 
for such technology.45 
 
[21] Healthcare providers will not be alone in making sure robots 
function properly and perform desirably in the healthcare setting. Robot 
complexity will increasingly bring developers, technicians, and data 
service providers into physical healthcare settings. These actors each bring 
their own data use practices and potential vulnerabilities into the 
healthcare environment. 
 
[22] Privacy and security challenges will be further magnified if, 
instead of just accessing information from other devices, robots actually 
physically merge with other devices. RoboLaw explains that personal care 
robots “could mutate function and form by inserting or removing other 
electronic devices (smart phones, tablets, etc.) and various ambient-
assisted living tools (including equipment for diagnostics, monitoring and 
control). This thus involves a mass of personal information that should be 
protected.”46 
 
[23] The pace at which robots are being developed and adopted could 
risk marginalizing certain security and privacy considerations if proper 
attention is not paid at all stages of design, deployment, and use. As 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
44 See Andrew Proia, Drew Simshaw & Kris Hauser, Consumer Cloud Robotics and the 
Fair Information Practice Principles: Recognizing the Challenges and Opportunities 
Ahead, 16 MINN. J.L. SCI. & TECH. 145, 153 (2015).  
 
45 See id. at 149. 
 
46 ROBOLAW, supra note 35, at 175. 
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robotics in healthcare advances, it will be important to constantly 
reexamine existing and emerging data practices, to evaluate the ways and 
by whom data will be collected, processed, stored, and used, and to gauge 
the awareness of roboticists and manufacturers when it comes to the 
resulting regulatory challenges, outlined below. 
 
V.  THE CURRENT REGULATORY FRAMEWORK 	  
[24] Indeterminacy as to the application of regulatory models, or just 
unsubtle gaps in regulation, causes regulatory turbulence. In the short 
term, a lack of effective regulation can lead to harms, be they physical or 
informational. Indeterminacy can also cause markets to fail with 
manufacturers or consumers electing to “sit out” in light of the confusion. 
In the medium or longer term, real or perceived harms may lead to 
regulatory “patches,” which may under-regulate out of fear of stifling 
innovation.47 Regulators may also under-regulate by making a category 
error, regulating with inapt rules or the “wrong” agency. The most serious 
episodes of turbulence can lead to regulatory disruption (and considerable 
consumer or patient harms) or regulatory arbitrage whereby providers or 
sellers migrate to the least regulated domains.48 Likely the most pressing 
issues involving the regulation of robots in healthcare will be device 
regulation and data protection.  
 
A.  Device Regulation 	  
[25] There is no doubt that some current and future health care robots 
are or will be subject to regulation by the FDA as “medical devices.” 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
47 See Joe Harpaz, How Regulation Stifles Technological Innovation, DAILY RECKONING 
(May 6, 2014), http://dailyreckoning.com/how-regulation-stifles-technological-
innovation/, archived at https://perma.cc/NRC4-M9WQ.  
 
48 See generally Nicolas P. Terry, Chad S. Priest & Paul P. Szotek, Google Glass and 
Health Care: Initial Legal and Ethical Questions, 8 J. HEALTH & LIFE SCI. L. 93, 93 
(2015) (discussing the legal issues, such as privacy and the necessary compliance with 
the Health Insurance Portability and Accountability Act, with the use of Google Glass in 
the healthcare setting).  
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Devices subject to such regulation are broadly defined as any 
 
instrument, apparatus, implement, machine, contrivance, 
implant, in vitro reagent, or other similar or related article, 
including any component part, or accessory which is . . . 
intended for use in the diagnosis of disease or other 
conditions, or in the cure, mitigation, treatment, or 
prevention of disease, in man or other animals, or . . . 
intended to affect the structure or any function of the body 
of man or other animals.49 
 
These medical devices are subject to safety regulations enforced by the 
Center for Devices and Radiological Health.50 Crucially, such devices are 
subject to premarket review if they are being marketed for the first time, if 
a new intended use is proposed, or if changes are made to the devices that 
could significantly affect safety or effectiveness.  
 
[26] Some currently regulated medical devices may begin to display 
autonomous or semi-autonomous characteristics. For example, robotic 
surgical systems designed to perform independently of physicians51 or the 
semi-autonomous Sedasys anesthesiology machine.52 These systems will 
likely continue to be regulated as medical devices as they evolve. Less 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
49 Federal Food, Drug, and Cosmetic Act § 201(h), 21 U.S.C. § 321 (2014).  
 
50 See About the Center for Devices and Radiological Health, U.S. FOOD & DRUG 
ADMIN., 
http://www.fda.gov/AboutFDA/CentersOffices/OfficeofMedicalProductsandTobacco/CD
RH/, archived at https://perma.cc/3B4N-MHZY (last visited Feb. 2, 2015). 
 
51 See Berkeley’s Autonomous Surgical Robotic System, supra note 28 (“Researchers at 
UC Berkeley have been working on getting a da Vinci surgical system to be smart 
enough to do some basic tasks on its own.”). 
 
52 See Todd C. Frankel, New machine could one day replace anesthesiologists, WASH. 
POST (May 11, 2015), http://www.washingtonpost.com/business/economy/new-machine-
could-one-day-replace-anesthesiologists/2015/05/11/92e8a42c-f424-11e4-b2f3-
af5479e6bbdd_story.html, archived at https://perma.cc/X6TW-Y7U6. 
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clear, however, is how the FDA will treat more custodial robots that 
initially perform only “routine tasks,” but slowly begin taking on more or 
ministerial healthcare tasks. Similar questions will arise as personal 
consumer robots in the home perform an increasing number of tasks that 
could be considered medical. 
 
[27] Robotics is not the only emerging healthcare technology. Similar 
issues of regulatory turbulence, even disruption, are posed by the growth 
of mobile platforms, medical apps, and wearables. 53  Overlapping 
questions arise between these technologies and robotics, including the 
migration of “professional” medical technologies such as sensors and 
analytical software into consumer space, the shock to consumer or patient 
expectations as their medical information leaves the safety of the HIPAA-
policed domain to a HIPAA-free zone, and the likelihood that medical 
apps will become increasingly smarter until their diagnostic prowess 
begins to look suspiciously like the “practice of medicine.” 
 
[28] Therefore, to understand which robots will be regulated as medical 
devices, it is helpful to examine the FDA’s guidance on its regulation of 
mobile medical applications.54 First released in 2013, this nonbinding 
guidance on “mHealth apps” took a risk-based approach to regulation of 
these emerging technologies.55 The agency limited its scrutiny to “only 
those mobile apps that are medical devices and whose functionality could 
pose a risk to a patient’s safety if the mobile app were to not function as 
intended.”56 Accordingly, the FDA will not regulate low risk apps that 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
53 See generally Nicolas Terry, Mobile Health: Assessing the Barriers, 147 CHEST J. 
1429–34 (May 2015). 
 
54 See generally Mobile Medical Applications: Guidance for Industry and Food and Drug 
Administration Staff, U.S. FOOD & DRUG ADMIN. (Feb. 9, 2015), 
http://www.fda.gov/downloads/MedicalDevices/DeviceRegulationandGuidance/Guidanc
eDocuments/UCM263366.pdf), archived at https://perma.cc/2LUN-KWQA (expressing 
the FDA’s current thinking on regulation of mobile medical applications and devices). 
 
55 See id. at 4. 
 
56 Id. at 4. 
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only coach, prompt, or help patients communicate with providers, nor will 
it regulate apps that serve as “fitness trackers” or “wellness coaches.”57 
The agency will regulate apps that act as substitutes for existing medical 
devices, but these apps will likely only require a premarket submission 
establishing substantial equivalence to an existing legally marketed 
device.58 Finally, device regulation will apply to apps performing patient-
specific analysis or providing patient-specific diagnosis or treatment 
recommendations.59 Like mobile apps, robots may adopt many of these 
functions. Unlike apps, however, robots will be able to go further and 
physically and socially interact with the user, creating additional 
concerns.60 In the end, there may be a potential merger between mobile 
apps and robots as mobile assistants, such as Apple’s Siri,61 continue to 
develop on mobile platforms. 
 
[29] If the FDA takes a similar approach to robot regulation, we could 
expect that a robot’s specific functions would determine whether it is 
subject to device regulation. Device regulation should continue to apply 
for robots that are developed as increasingly autonomous versions of 
existing medical devices. For new devices, the level of autonomy and 
amount of doctor supervision might determine whether the FDA considers 
a robot safe enough. For example, the Sedasys system, a “computer-
assisted personalized sedation machine,” was initially rejected by the FDA 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
57 See id. at 15–16. 
 
58 As later sections will demonstrate, data associated with robots that resemble these apps 
will still face protection issues because in many cases HIPAA will not apply, and the 
FTC will only get involved if the robot deviated from its privacy policy. See infra Section 
IV.B. 
 
59 See Mobile Medical Applications: Guidance for Industry and Food and Drug 
Administration Staff, supra note 56, at 13–15.  
 
60 See M. Ryan Calo, Robots and Privacy, in ROBOT ETHICS: THE ETHICAL AND SOCIAL 
IMPLICATIONS OF ROBOTICS 187–90 (Patrick Lin et al. eds., 2012). 
 
61 See Siri, APPLE, http://www.apple.com/ios/siri/, archived at https://perma.cc/HH2M-
PEUX (last visited Feb. 2, 2016). 
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in 2010 over safety concerns, and was approved in 2013 only after 
Johnson & Johnson agreed to only use the system for simple procedures, 
like colonoscopies, and to require an anesthesiologist to be on-call to 
handle any emergencies.62 For robots that begin by performing routine or 
non-medical tasks, but evolve into what we might consider “healthcare” or 
“medical” robots, their qualification as “medical devices” may depend on 
the specific functions adopted. FDA clearly believes that most mobile 
health apps are benign, ranging from the recreational to very low risk. 
Given the agency’s experience with surgical robots,63 it is unlikely that 
FDA will take a hands-off or regulation-lite approach to any robots that 
have significant interactions with patients. 
 
[30] To the extent that certain robots will be regulated as medical 
devices, two additional FDA guidance documents produced in recent years 
are particularly relevant to robots in healthcare. First, the FDA has 
acknowledged that “[c]hanges in health care have moved care from the 
hospital environment to the home environment,” and that “[a]s patients 
move to the use of home health care services for recuperation or long-term 
care, the medical devices necessary for their care have followed them.”64 
Accordingly, the FDA offers special guidance for home use devices,65 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
62 See Frankel, supra note 52.  
 
63 Letter from Elizabeth A. Kage, Acting Dist. Dir. Pub. Health Servs., Food & Drug 
Admin., to Gary S. Guthart, President and CEO, Intuitive Surgical, Inc. (July 16, 2013) 
(on file with FDA), 
http://www.fda.gov/ICECI/EnforcementActions/WarningLetters/2013/ucm363260.htm, 
archived at https://perma.cc/B6YH-GA43. 
 
64 See Home Use Devices, U.S. FOOD & DRUG ADMIN., 
http://www.fda.gov/MedicalDevices/ProductsandMedicalProcedures/HomeHealthandCo
nsumer/HomeUseDevices/default.htm, archived at https://perma.cc/H69V-KSN9 
(accessed by searching for page in archive.org).  
 
65 See, e.g., Design Considerations for Devices Intended for Home Use: Guidance for 
Industry and Food and Drug Administration Staff, U.S. FOOD & DRUG ADMIN. 1 (Nov. 
24, 2014), 
http://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/GuidanceDocument
s/ucm331675.htm, archived at https://perma.cc/4H4Q-TQFF; Medical Device Home Use 
Initiative, U.S. FOOD & DRUG ADMIN. 7 (Apr. 2010), 
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which outline some of the unique safety challenges presented in the home, 
including “risks result[ing] from interactions among the user, the use 
environment, and the device, [which] can greatly affect user and patient 
safety.”66 Aimed at manufacturers, the guidance stresses that “[t]hese risks 
are best addressed at the design stage.”67 Many of the safety challenges 
described will be the same—or, more likely, magnified—with robots. This 
includes reliance on wireless signals that may be unavailable in certain 
parts of the home,68 and the need to recognize certain “human factors” 
which require “[u]nderstanding and optimizing how people use and 
interact with technology.”69 This guidance indicates the FDA’s awareness 
and appreciation of the changing healthcare landscape, and the 
unstructured environment in which healthcare robots will be operating in 
the coming years. 
 
[31] However, the challenges presented by personal care robots, 
specifically, will differ from both medical devices and other robots. 
RoboLaw has explained, for instance, that personal care robots “greatly 
change the concept of ‘safety’ because, unlike industrial robots: (i) they 
need to be used for a wide range of requirements in environments that are 
not well defined; (ii) they are used by non-specialist users; and (iii) they 
share work space with humans.”70 Premarket review of “safety” for robots 
must account for these unique considerations. 
 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
http://www.fda.gov/downloads/MedicalDevices/ProductsandMedicalProcedures/HomeH
ealthandConsumer/HomeUseDevices/UCM209056.pdf, archived at 
https://perma.cc/56N8-XB4L. 
 
66 Design Considerations for Devices Intended for Home Use: Guidance for Industry and 
Food and Drug Administration Staff, supra note 65, at 2. 
 
67 Id. 
 
68 See id. at 4. 
 
69 Id. at 13. 
 
70 ROBOLAW, supra note 35, at 174. 
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[32] The FDA’s recent cybersecurity guidance for medical device 
manufacturers is also especially relevant to robots in healthcare—
particularly those connected to the Internet in the hospital or the home.71 
This guidance recommends that manufacturers “consider cybersecurity 
risks as part of the design and development of a medical device, and 
submit documentation to the FDA about the risks identified and controls 
in place to mitigate those risks.”72 In addition, the FDA released a “safety 
communication” to manufacturers and healthcare organizations that listed 
recommendations designed to mitigate cybersecurity risks to medical 
devices.73 The FDA has also opened a cybersecurity lab to test medical 
devices.74 
 
[33] Robot designers and manufacturers should be aware of the FDA’s 
emphasis on cybersecurity to ensure successful deployment, because even 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
71 See Content of Premarket Submissions for Management of Cybersecurity in Medical 
Devices: Guidance for Industry and Food and Drug Administration Staff, U.S. FOOD & 
DRUG ADMIN. 4 (Oct. 2, 2014), 
http://www.fda.gov/downloads/MedicalDevices/DeviceRegulationandGuidance/Guidanc
eDocuments/UCM356190.pdf, archived at https://perma.cc/M3WH-5V5W. 
 
72 Press Release, Food & Drug Admin., The FDA takes steps to strengthen cybersecurity 
of medical devices (Oct. 1, 2014), 
http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm416809.htm, 
archived at https://perma.cc/JB5H-746P (The FDA recently held a public forum “to 
discuss how government, medical device developers, hospitals, cybersecurity 
professionals, and other stakeholders can collaborate to improve the cybersecurity of 
medical devices and protect the public health.”).  
 
73 See Cybersecurity for Medical Devices and Hospital Networks: FDA Safety 
Communication, U.S. FOOD & DRUG ADMIN. (June 13, 2013), 
http://www.fda.gov/MedicalDevices/Safety/AlertsandNotices/ucm356423.htm, archived 
at https://perma.cc/J6UQ-6K55 [hereinafter FDA Safety Communication]. 
 
74 See Emily Wasserman, FDA beefs up cybersecurity efforts to ensure safety standards, 
FIERCEMEDICAL DEVICES (June 6, 2014), 
http://www.fiercemedicaldevices.com/story/fda-beefs-cybersecurity-efforts-ensure-
safety-standards/2014-06-06, archived at https://perma.cc/2HHQ-8G3T (“The agency . . . 
created a ‘cybersecurity laboratory,’ which stages deliberate cybersecurity attacks to sniff 
out any defects that could leave a device open to attack.”).  
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though the current guidelines are merely recommendations, they may 
become de facto requirements in the future.75  Hospital networks are 
notoriously insecure. 76  Subjecting robots to this environment only 
magnifies vulnerabilities already posed to regular medical devices and 
electronic health records. Indeed, the threats to physical safety caused by 
insecure medical devices of all kinds are real, leaving pacemakers, 
defibrillators, insulin pumps, and other devices vulnerable to hacks.77 
These threats may be magnified with robots due to their ability to 
manipulate their surroundings. Robots used in the home may encounter 
even more vulnerable environments with less physical and cyber security 
and even less sophisticated users. 
 
[34] Although the FDA’s recent emphasis on cybersecurity may 
ultimately result in more secure robots, its review is only focused on 
threats as they relate to device functionality and the resulting effect on 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
75 See Philip Desjardins, FDA Scrutinizes Networked Medical Device Security, 
INFORMATIONWEEK (Dec. 1, 2014), 
http://www.informationweek.com/healthcare/security-and-privacy/fda-scrutinizes-
networked-medical-device-security/a/d-id/1317758, archived at https://perma.cc/6P8R-
HCXG (“By outlining cyber security premarket submission content recommendations, 
the FDA could lay the groundwork for a new category of de facto required information 
that will be needed for the agency to adequately review premarket submissions for 
connected devices.”). 
 
76 See, e.g., FDA Safety Communication, supra note 73 (“Recently, the FDA has become 
aware of cybersecurity vulnerabilities and incidents that could directly impact medical 
devices or hospital network operations.”); Chad Garland, Hackers stole 4.5 million 
patients' data in hospital breach, L.A. TIMES (Aug. 18, 2014, 1:18 PM), 
http://www.latimes.com/business/technology/la-fi-tn-community-health-hacked-
20140818-story.html, archived at https://perma.cc/5WXR-8VCT. 
 
77 See, e.g., David F. Carr, Hackers Outsmart Pacemakers, Fitbits: Worried Yet?, 
INFORMATIONWEEK (Dec. 12, 2013), 
http://www.informationweek.com/healthcare/security-and-privacy/hackers-outsmart-
pacemakers-fitbits-worried-yet/d/d-id/1113000, archived at https://perma.cc/LH8S-
GDYP (describing how “cybersecurity researchers have demonstrated the potential to 
hack[] pacemakers, defibrillators, insulin pumps, and other devices that could have life-
or-death consequences”). 
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physical safety, and not necessarily potential broader harms. Device 
functionality is important, but should not cause stakeholders to overlook 
the notion that the data associated with devices are often a more valuable 
target than the devices themselves. 78  Attention to certain security 
vulnerabilities is marginalized under current device regulation, specifically 
those security vulnerabilities that do not necessarily affect a patient’s 
physical safety, but may nevertheless lead to unauthorized access to and 
use of valuable and sensitive health information, of which robots will have 
an unprecedented amount. 
 
[35] The natural inclination in response to this apparent shortcoming is 
to look to HIPAA as the widely accepted health information privacy law. 
Indeed, users of traditional medical devices controlled by covered entities 
have HIPAA to rely on for some health information disclosure protections. 
But, as the following section describes, this is not the case with certain 
private consumer robots operating outside of HIPAA’s domain. After 
these robots are made available to the public, users will rely heavily on the 
FTC for security and privacy protection.79 Even robots that are regulated 
by the FDA and subject to HIPAA, though, are developed without 
mandated proactive consideration of information security and privacy by 
design. Current devices with limited functions, and correspondingly 
limited safety, privacy, and security concerns, might be adequately served 
by current regulation schemes; but robots might prove to be the 
technology that brings to light the need for more or restructured security 
and privacy oversight, especially by the FTC. 
 
B.  Data Protection 	  
[36] Healthcare data challenges are well known. For example, hospitals 
and medical devices have been identified in recent years as being 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
78 See Klint Finley, Hacked Fridges Aren’t the Internet of Things’ Biggest Worry, WIRED 
(Mar. 12, 2015), http://www.wired.com/2015/03/hacked-fridges-arent-internet-things-
biggest-worry/, archived at https://perma.cc/Y45F-HY6P (“[I]n the business of hacking, 
it’s not the device that’s valuable. It’s the data they generate.”). 
 
79 See infra Section IV.B. 
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notoriously insecure.80 There is also a dichotomy, albeit frequently a false 
one, between strong privacy protections and provider, researcher, and 
policymaker calls for unfettered data collection, liquidity, and (secondary) 
use. Robots in healthcare will magnify these challenges. Overall, as 
described in previous sections, data that are necessary and desirable to 
enable effective use of robots in healthcare will represent an 
unprecedented generation and centralization of health and other sensitive 
information, much of which is inadequately considered under current 
regulation. 81  AI-based devices pose a particular challenge to data 
protection principles because they thrive on the collection and analysis of 
vast amounts of data. While Fair Information Practice Principles (such as 
data minimization and respect for context) make sense in human-human 
interactions, it may be too early to articulate any limits on data collection 
by robots.82 
 
1.  Robot-Carried PHI in HIPAA-Protected Space 
 
[37] Most personal health information generated, shared, and utilized 
by robots in the traditional healthcare setting will be subject to the Health 
Insurance Portability and Accountability Act (HIPAA) Privacy and 
Security Rules. The HIPAA Privacy Rule “provides federal protections for 
individually identifiable health information held by covered entities and 
their business associates,” on whom the rule places duties, which are 
enforced by the U.S. Department of Health and Human Services (HHS) 
Office of Civil Rights (OCR).83 The HIPAA Security Rule, also enforced 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
80 See, e.g., FDA Safety Communication, supra note 73; Garland, supra note 76. 
 
81 See, e.g., Thierer, supra note 43. 
 
82 See NAT’L INST. OF STANDARDS AND TECH., APPENDIX A-FAIR INFORMATION 
PRACTICE PRINCIPLES (FIPPS), http://www.nist.gov/nstic/NSTIC-FIPPs.pdf, archived at 
https://perma.cc/Q2BU-UGGS. 
 
83 See 45 C.F.R. § 160 (2014); 45 C.F.R. § 164(A, E) (2014); see also Understanding 
Health Information Privacy, U.S. DEP’T OF HEALTH & HUMAN SERVS., 
http://www.hhs.gov/ocr/privacy/hipaa/understanding/, archived at https://perma.cc/27C9-
DRR3. 
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by OCR, “specifies a series of administrative, physical, and technical 
safeguards for covered entities and their business associates to use to 
assure the confidentiality, integrity, and availability of electronic protected 
health information.”84 A covered entity is defined as a health plan, a health 
care clearinghouse, or a health care provider who electronically transmits 
any health information in connection with transactions for which HHS has 
adopted standards.85 A business associate is “a person or entity that 
performs certain functions or activities that involve the use or disclosure 
of protected health information on behalf of, or provides services to, a 
covered entity.”86 It is important to note that, to the extent that HIPAA 
applies to certain robots in healthcare, it only accounts for disclosures of 
information after that information is collected.87 Missing from current 
regulation is a proactive, pre-deployment mandate to incorporate security 
and privacy protections of information into the design of robotic systems, 
similar to the way the FDA proactively regulates physical safety.88 
 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
84 See 45 C.F.R. § 160 (2014); 45 C.F.R. § 164(A, C) (2014); see also Understanding 
Health Information Privacy, supra note 83. 
 
85 See 45 C.F.R. § 160.103 (2014); see also To Whom Does the Privacy Rule Apply and 
Whom Will It Affect?, NAT’L INST. HEALTH, 
http://privacyruleandresearch.nih.gov/pr_06.asp, archived at https://perma.cc/2U3Z-
2A7B. 
 
86 Health Information Privacy, U.S. DEP’T OF HEALTH & HUMAN SERVS., 
http://www.hhs.gov/ocr/privacy/hipaa/understanding/coveredentities/businessassociates.h
tml, archived at https://perma.cc/YCE3-QLSB; 45 C.F.R. § 160.103 (2014) (definition of 
“business associate”). 
 
87 See Nicolas P. Terry, Protecting Patient Privacy in the Age of Big Data, 81 UMKC L. 
REV. 385, 386–87 (2012) (“[W]hile HIPAA/HITECH provide increasingly robust 
protections against unauthorized uses of health information by a relatively narrow set of 
traditional health care provider data stewards, it does almost nothing to regulate the 
collection of health data. This is because the HIPAA Privacy Rule is a misnomer. It is not 
a privacy rule because it only protects against data disclosure not against data collection.  
It is therefore more appropriately described as a confidentiality rule.”). 
 
88 See supra Part IV.A. 
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[38] Because the vast majority of hospitals are HIPAA covered entities, 
identifiable health information collected by robots under the control of 
hospitals or their business associates will be subject to the Privacy and 
Security Rules. HIPAA thoroughly accounts for disclosure practices of 
identifiable health information held by covered entities, but these practices 
will become increasingly complex as robots in healthcare utilize more 
third parties on a regular basis, such as cloud service providers.89 Robots 
in healthcare will highlight the fact that these essential and highly 
involved “business associates” are now directly liable for their violations 
under the HIPAA final omnibus rule, as opposed to only being 
accountable under their mandated contracts with covered entities. 90 
Overall, and as previous sections have described, robots in healthcare 
greatly expand not only the sheer amount of personal health information 
that is collected, but also the ways in which data are processed, stored, and 
used, and by whom, complicating privacy and security compliance efforts 
in the hospital setting. 
 
2.  Robot-Carried PHI outside HIPAA-Protected Space 
 
[39] While most data collected and used by healthcare robots operating 
within a hospital environment will be subject to the HIPAA rules, the 
same cannot be said for many other robots involved in healthcare. Overall, 
far more difficult data protection questions arise outside of conventional 
healthcare. If robots are being deployed for medical purposes, healthcare, 
or comfort by persons who are not covered entities or their business 
associates, the HIPAA Privacy and Security Rules do not apply. 
 
[40] Issues will arise as the healthcare setting expands to the home, 
where many popular health technologies currently operate outside of 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
89 See supra Part II. 
 
90 See Modifications to the HIPAA Privacy, Security, Enforcement, and Breach 
Notification Rules Under the Health Information Technology for Economic and Clinical 
Health Act and the Genetic Information Nondiscrimination Act; Other Modifications to 
the HIPAA Rules, 78 Fed. Reg. 5,566 (Jan. 25, 2013) (to be codified at 45 C.F.R. pts. 
160 & 164). 
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HIPAA’s domain, including personal “wearables” such as Fitbit91 and the 
aforementioned mobile medical apps.92 But even those robots in the home 
that are subject to HIPAA will encounter a wide range of data protection 
challenges. For example, a recent Boston Children’s Hospital pilot 
programs sent monitoring robots home with children who had urological 
surgery. 93  In situations like these, and especially as robot functions 
become more complex, challenges may stem from the fact that robots in 
the home need to collect vast amounts of information about users and their 
environment, 94  even beyond the health information protected under 
HIPAA.95 
 
[41] Less complicated, but also less satisfying, is the privacy-security 
regulation of home robots that are not supplied by HIPAA entities. As 
previous sections have described, some of these robots may be regulated 
for physical safety by the FDA, including cybersecurity to the extent that 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
91 See Fitbit, http://www.fitbit.com, archived at https://perma.cc/CG7A-6CT3 (last 
visited Feb. 2, 2016). 
 
92 See supra Part IV.A. 
 
93 See Erin McCann, Health IT Promises New Paradigm of Patient Care, HEALTHCARE 
IT NEWS (Sept. 12, 2012, 3:49 PM), http://www.healthcareitnews.com/news/health-it-
promises-new-paradigm-patient-care, archived at https://perma.cc/Y88C-42WB. 
 
94 See Proia, Simshaw & Hauser, supra note 44, at 157 (describing the data collection 
practices of household robots, including the “detailed mapping of buildings and rooms, as 
well as particular data on objects within that environment, including data that will help 
determine what the object is and where the object is located”). 
 
95 See, e.g., Cocco, supra note 34, at 104 (noting that this is the case with smart home 
technology for the elderly, as, “[t]he kinds of information collected and transmitted by 
smart home technology go beyond the scope of the definition [of protected health 
information]. While the information pertaining to a resident’s heart rate, respiration, and 
medication intake will most likely be protected, information about his or her location in 
the home over time would most likely not be. To consider information regarding whether 
someone missed a television show or used the sink ‘protected health information’ would 
be a stretch of the definition.”). 
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it affects device functionality, but not broader privacy-security harms.96 In 
addition, HIPAA will govern the disclosure of certain protected health 
information, but only if that information is collected and controlled by 
covered entities, which might not always be the case in the home setting. 
 
[42] Examples of these household robots may emerge if domestic 
consumer “personal assistant” robots (such as Jibo 97  and Pepper 98 ), 
unaffiliated with any covered entity, begin taking on healthcare-related 
tasks such as monitoring an individual’s daily activity, issuing medication 
reminders, and suggesting when to seek medical assistance if it senses 
something wrong. Because these robots are unaffiliated with any covered 
entity, they will not be subject to the HIPAA Privacy and Security Rules. 
 
[43] It does not follow, though, that these robots will be completely 
unregulated. Indeed, some oversight such as FDA device, and hence 
cybersecurity, regulation likely would still apply.99 However, the data 
protection model is more complicated and ultimately less satisfactory. In 
the case of mobile medical apps that fall outside of HIPAA protection, it is 
still possible that some state privacy laws may apply, but by their terms 
even the most pro-privacy of these 100  would not currently apply to 
“consumer” robots operating in a “HIPAA-free zone.”101 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
96 See supra Part IV.A. 
 
97 See JIBO, http://www.jibo.com, archived at https://perma.cc/62TM-3QSL (last visited 
Jan. 29, 2016). 
 
98 See Who Is Pepper?, ALDEBARAN, https://www.aldebaran.com/en/a-robots/who-is-
pepper, archived at https://perma.cc/HM3B-EX5U (last visited Jan. 17, 2016). 
 
99 See supra Part IV.A. 
 
100 See generally California Confidentiality of Medical Information Act (CMIA), CAL. 
CIV. CODE § 56.06 (Deering 2015) (demonstrating California state privacy law may apply 
to mobile medical apps). 
 
101 See Terry, supra note 87, at 387 (“The health care sector and its stakeholders 
constitute an area considerably larger than the HIPAA-regulated zone. As a result, some 
traditional health information circulates in what may be termed a HIPAA-free zone.”). 
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[44] Rather, most responsibility in such cases would fall on the FTC.  
The FTC has become increasingly active in consumer privacy matters 
related to the Internet of Things,102 big data, 103 and data brokers,104 all of 
which have had significant impact on health information in recent years.  
The agency is likely to play a critical role in any attempt to regulate 
consumer robots, which may become more widespread in the near 
future.105  The FTC does not differentiate between health data protection 
in conventional and emerging healthcare spaces.106 Rather, it protects data 
somewhat indirectly, by enforcing privacy policies or otherwise 
characterizing bad data practices as unfair or misleading.107 This agency’s 
role may expand in the coming years, as robots might prove to be the 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
102 See, e.g., FED. TRADE COMM’N, INTERNET OF THINGS: PRIVACY & SECURITY IN A 
CONNECTED WORLD i (2015), 
https://www.ftc.gov/system/files/documents/reports/federal-trade-commission-staff-
report-november-2013-workshop-entitled-internet-things-privacy/150127iotrpt.pdf, 
archived at https://perma.cc/BK9Y-XUEN [hereinafter FTC IoT Report]. 
 
103 See, e.g., Big Data: A Tool for Inclusion or Exclusion?, FED. TRADE COMM’N (Sept. 
15, 2014), https://www.ftc.gov/news-events/events-calendar/2014/09/big-data-tool-
inclusion-or-exclusion, archived at https://perma.cc/SK5G-PJX5. 
 
104 See, e.g., FED. TRADE COMM’N, DATA BROKERS: A CALL FOR TRANSPARENCY AND 
ACCOUNTABILITY i (May 2014), 
https://www.ftc.gov/system/files/documents/reports/data-brokers-call-transparency-
accountability-report-federal-trade-commission-may-2014/140527databrokerreport.pdf, 
archived at https://perma.cc/B2Q5-7FM2. 
 
105 See generally Proia, Simshaw & Hauser, supra note 44, at 161–63 (explaining that 
“privacy advocates and policymakers will likely look to the . . . [FTC framework] to 
determine the adequacy of cloud robotics companies’ data practices”). 
 
106 See In re LabMD, Inc.: Case Summary, FED. TRADE COMM’N, 
https://www.ftc.gov/enforcement/cases-proceedings/102-3099/labmd-inc-matter, 
archived at https://perma.cc/P7RM-UZG2 (last updated Dec. 18, 2015). 
 
107 See Julie Brill, Comm’r, Fed. Trade Comm’n, Keynote Address at EuroForum 
European Data Protection Days: Data Protection and the Internet of Things 6 (May 4, 
2015), https://www.ftc.gov/system/files/documents/public_statements/640741/2015-05-
04_euroforum_iot_brill_final.pdf, archived at https://perma.cc/3SWK-X599. 
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technology that brings to light the need for more or restructured security 
and privacy oversight. 
 
[45] However, the FTC is limited both in its powers and its resources.  
Section 5 of the Federal Trade Commission Act (FTC Act) generally 
authorizes the FTC to investigate and prevent deceptive trade practices.108 
It should be noted, however, that FTC jurisdiction is almost entirely ex 
post facto. That is, unlike the FDA’s intervention with regard to some 
classes of medical devices, the FTC does not perform pre-marketing 
scrutiny or approval.109 
 
[46] There are three areas where it is likely that the FTC would become 
involved in regulating robots in the home. First, as with any other 
consumer product, the FTC will intervene if the product is deceptively 
advertised. For example in the “mole app cases,” the defendants’ apps 
used smartphone images to calculate the risk of skin imperfections being 
pre-cancerous or cancerous.110 Personal assistant robots in the home may 
very well attempt to perform similar diagnostic functions, and if they do, 
may be subject to FTC enforcement. 
 
[47] Second, the FTC may argue that, as in the Wyndham Hotels 
litigation, providing a product or service (including, presumably, home 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
108 See 15 U.S.C. § 45(a)(1) (2012) (“[U]nfair methods of competition in or affecting 
commerce, and unfair or deceptive acts or practices in or affecting commerce, are hereby 
declared unlawful.”). 
 
109 See Resp’t LabMd, Inc.’s Mot. to Dismiss Compl. with Prejudice & to Stay Admin. 
Proceedings at 22, In re LabMD, Inc., No. 9357 (F.T.C. Nov. 12, 2013), 
https://www.ftc.gov/sites/default/files/documents/cases/131112respondlabmdmodiscompl
aintdatyadminproceed.pdf, archived at https://perma.cc/M474-GTTY. 
 
110 See In re Health Discovery Corp., No. C-4516, at 2 (F.T.C. Apr. 13, 2015), 
https://www.ftc.gov/system/files/documents/cases/150413hdcmelappdo.pdf, archived at 
https://perma.cc/CPT2-GLWV; Fed. Trade Comm’n v. Lasarow, et al., No. 15-cv-1614, 
at 2, 4 (N.D. Ill. 2015), 
https://www.ftc.gov/system/files/documents/cases/150223avromorder.pdf, archived at 
https://perma.cc/TE29-RNM4.  
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monitoring and robotic services) with inadequate data security by itself 
constitutes an “unfair practice.”111 
 
[48] Third, and where the FTC has placed most of its energy in privacy 
cases, it may argue that the supply of a product or service with an 
inaccurate privacy policy, or where the supplier fails to comply with its 
own announced privacy or security policies, is a deceptive or misleading 
practice.112 
 
[49] Traditionally, the FTC’s consumer protections have only applied to 
health information to the extent that it represents one of the many kinds of 
“sensitive” information with which the agency is concerned.113  However, 
recent proposals by the White House and the FTC itself indicate that the 
role of the FTC in protecting health information, both with HIPAA 
covered entities and in the HIPAA-free zone, may be expanding. The 
security and privacy issues arising with robots in healthcare, currently 
marginalized under existing regulatory frameworks, demonstrate why the 
FTC may play a critical role in encouraging concepts such as privacy and 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
111 See Fed. Trade Comm’n v. Wyndham Worldwide Corp., 799 F.3d 236, 240 (3rd Cir. 
2015) [hereinafter Wyndham]; see also Compl. at 4–5, In re LabMD, Inc., No. 9357 
(F.T.C. Aug. 28, 2013), 
https://www.ftc.gov/sites/default/files/documents/cases/2013/08/130829labmdpart3.pdf, 
archived at https://perma.cc/H3XD-CBNT (redacted public version) (showing that the 
FTC is again using the ‘unfair practices’ argument in breached consumer data cases). 
 
112 See Press Release, Fed. Trade Comm’n, Medical Billing Provider and its Former CEO 
Settle FTC Charges That They Misled Consumers About Collection of Personal Health 
Data (Dec. 3, 2014), https://www.ftc.gov/news-events/press-releases/2014/12/medical-
billing-provider-its-former-ceo-settle-ftc-charges-they, archived at 
https://perma.cc/658N-TJHN; Press Release, Fed. Trade Comm’n, Fandango, Credit 
Karma Settle FTC Charges that They Deceived Consumers By Failing to Securely 
Transmit Sensitive Personal Information (Mar. 28, 2014), https://www.ftc.gov/news-
events/press-releases/2014/03/fandango-credit-karma-settle-ftc-charges-they-deceived-
consumers, archived at https://perma.cc/JUD6-9AWL. 
 
113 See generally Proia, Simshaw, & Hauser, supra note 44, at 181, 183 (explaining the 
heightened focus on certain Fair Information Practice Principles necessary when sensitive 
information is involved). 
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security by design, which will help maintain responsible design and 
deployment of robots in the coming years and enable further innovation in 
this critical area. 
 
[50] As recently as 2012, the FTC’s report “Protecting Consumer 
Privacy in an Era of Rapid Change: Recommendations For Businesses and 
Policymakers” implied that HIPAA’s Privacy and Security Rules 
adequately protect health information.114 
 
[51] However, in the years since, smartphone platforms, wearables, and 
big data brokers operating in the HIPAA-free zone have caused what 
appears to be a shift in policy.115 The White House’s 2015 draft consumer 
privacy bill seemed to indicate support for a significant extension of FTC 
oversight into healthcare with its inclusion of certain medical data in the 
categories that are to be protected.116 Such dual regulation may seem 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
114 See FED. TRADE COMM’N, PROTECTING CONSUMER PRIVACY IN AN ERA OF RAPID 
CHANGE: RECOMMENDATIONS FOR BUSINESSES AND POLICYMAKERS 16–17 (March 
2012), https://www.ftc.gov/reports/protecting-consumer-privacy-era-rapid-change-
recommendations-businesses-policymakers, archived at https://perma.cc/PU2L-BFGR; 
see also Nicolas Terry, Should Health Lawyers Pay Attention To The Administration’s 
Privacy Bill?, HEALTH AFF. BLOG (Mar. 13, 2015), 
http://healthaffairs.org/blog/2015/03/13/should-health-lawyers-pay-attention-to-the-
administrations-privacy-bill/, archived at https://perma.cc/N9FK-Q67F (“The 
conventional wisdom implicit in the 2012 [FTC] reported was that health information 
was adequately protected by the domain-specific HIPAA Privacy and Security Rules, 
hence the HIPAA-entity exception in the framework and a similar provision in the FTC’s 
2012 offering.”). 
 
115 See Terry, supra note 114. 
 
116 See Administration Discussion Draft: Consumer Privacy Bill of Rights Act of 2015, at 
20, https://www.whitehouse.gov/sites/default/files/omb/legislative/letters/cpbr-act-of-
2015-discussion-draft.pdf, archived at https://perma.cc/5BKV-ATSZ; Terry, supra note 
114 (“[M]edical data clearly fall within the bill’s purview. The definition of personal data 
is quite broad (albeit likely not broad enough for many privacy advocates), includes non-
exclusive examples such as a ‘health care account number,’ and ‘any data that are 
collected, created, processed, used, disclosed, stored, or otherwise maintained and linked, 
or as a practical matter linkable by the covered entity’ to that numerical identifier.”). 
 
Richmond Journal of Law & Technology                             Volume XXII, Issue 2 
 
	   33 
duplicative, but in fact, such an approach could produce a successful 
regulatory scheme in which the FTC oversees the initial collection of 
health information, while HIPPA governs subsequent disclosure practices.  
In other words, the FTC will focus on general privacy and use of health 
and other sensitive information, and HIPPA will focus on sector-based 
confidentiality and disclosure of protected health information.117 
 
[52] One way to enable such a regulatory scheme is to remove the 
sector-based limitations currently limiting the FTC’s influence in 
healthcare.  Such an approach would “allow[] for true collection 
regulation, leaving HIPAA/HITECH to regulate the disclosure practices of 
covered entities. New privacy rules common to all sectors and limiting 
data collection would then sit upstream of existing health care regulation 
that would continue to deal with unauthorized information disclosure.”118 
 
[53] Privacy and security issues associated with robots in healthcare 
could be an area where the FTC is quite comfortable regulating, as many 
of the issues associated with such robots, and particularly with those that 
will provide care in the home, align with areas of focus of the agency. For 
one, robots in the home in general, and those performing healthcare tasks 
specifically, will be collecting data on a person’s most private matters, 
which, like smart home technology generally, has led to calls for increased 
regulation of such practices.119 These concerns mirror those expressed at 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
117 See Terry, supra note 87, at 406 (“[C]oncerns about duplicate burdens are 
unwarranted in the case of health care regulation. . . .  HIPAA/HITECH employs a 
sector-based confidentiality (disclosure-centric) model. The White House and to an 
extent the FTC proposals are primarily privacy (collection-centric) endorse models.”). 
 
118 Id. at 407 (explaining that “HIPAA's weakness . . . []the fact that it provides only a 
confidentiality model of protection[,] can be cast as a strength when it comes to 
compatibility with the White House and FTC collection-centric models of protection”). 
 
119 See, e.g., Cocco, supra note 34, at 106 (“The data at issue with smart homes could 
concern almost every detail of a person's life, including bathroom visits, interactions with 
other people, food intake, medications, sleep cycles, and physiological data. Thus, it is 
necessary to institute proper regulations to reconcile the interest in privacy protection in 
the home with this kind of pervasive technology.”). 
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the FTC’s 2013 workshop on the Internet of Things.120 In addition, the 
FTC has acknowledged the significance of the sheer volume of data that 
will be generated by home-connected devices.121 As with other home 
connected devices, health-related data gathered by a robot not affiliated 
with a HIPAA-covered entity could be used in the future for purposes not 
anticipated at the time of collection. 122  These uses would present 
challenging questions, even beyond privacy and security.123 Perhaps most 
significantly, the FTC has acknowledged the increasing problem of the 
“HIPAA-free zone,” and believes consumers should have transparency 
and choices over their sensitive information, regardless of who collects 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
120 See Fed. Trade Comm’n, Transcript, Internet of Things Workshop 67–68, 70–72 
(Nov. 19, 2013), http://www.ftc.gov/sites/default/files/documents/public_events/internet-
things-privacy-security-connected-world/final_transcript.pdf, archived at 
https://perma.cc/LYA6-AAUG [hereinafter IoT Workshop Transcript]; see also FTC IoT 
Report, supra note 102, at 14 (“Some of these risks involve the direct collection of 
sensitive personal information, such as precise geolocation, financial account numbers, or 
health information—risks already presented by traditional Internet and mobile commerce. 
Others arise from the collection of personal information, habits, locations, and physical 
conditions over time, which may allow an entity that has not directly collected sensitive 
information to infer it.”) (footnotes omitted). 
 
121 See FTC IoT Report, supra note 102, at 14 (“The sheer volume of data that even a 
small number of devices can generate is stunning: one participant indicated that fewer 
than 10,000 households using the company’s IoT home-automation product can ‘generate 
150 million discrete data points a day’ or approximately one data point every six seconds 
for each household.”) (footnotes omitted). 
 
122 See id. at 16 (“[O]ne researcher has hypothesized that although a consumer may today 
use a fitness tracker solely for wellness-related purposes, the data gathered by the device 
could be used in the future to price health or life insurance or to infer the user’s suitability 
for credit or employment (e.g., a conscientious exerciser is a good credit risk or will make 
a good employee). According to one commenter, it would be of particular concern if this 
type of decision-making were to systematically bias companies against certain groups 
that do not or cannot engage in the favorable conduct as much as others or lead to 
discriminatory practices against protected classes.”) (footnotes omitted). 
 
123 See, e.g., id. at 17 (implying a question of whether we want insurance companies to 
offer lower premiums to people who share data from their healthcare robot). 
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it.124 
 
[54] Because robots in healthcare are so difficult to place within 
existing regulatory frameworks, they demonstrate, perhaps even more than 
other emerging technologies and robots in general, how close some of 
these frameworks must come to each other in order to close gaps in 
protections for things like safety, security, and privacy.  The previously 
described dual (but not overlapping) FTC and HIPAA regulatory scheme 
is one example. The FTC has also expressed in its call for general data 
protection legislation an apparent willingness to align its goals with the 
FDA’s concern of physical safety: “General data security legislation 
should protect against unauthorized access to both personal information 
and device functionality itself.  For example, if a pacemaker is not 
properly secured, the concern is not merely that health information could 
be compromised, but also that a person wearing it could be seriously 
harmed.”125 So whereas OCR and the FDA may be unable or unwilling to 
expand their roles to account for the gaps in security and privacy 
protections that will be exposed by robots in healthcare, the FTC appears 
both able and willing to do so. 
 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
124 See id. at 51–52 (“HIPAA protects sensitive health information, such as medical 
diagnoses, names of medications, and health conditions, but only if it is collected by 
certain entities, such as a doctor’s office or insurance company. Increasingly, however, 
health apps are collecting this same information through consumer-facing products, to 
which HIPAA protections do not apply. Commission staff believes that consumers should 
have transparency and choices over their sensitive health information, regardless of who 
collects it.”); see also Susan D. Hall, FTC Report on IoT Calls for Update to HIPAA 
Standards, FIERCEHEALTHIT (Jan. 28, 2015), http://www.fiercehealthit.com/story/ftc-
report-internet-things-calls-updated-hipaa-standards/2015-01-28, archived at 
https://perma.cc/Z487-K9N9 (“[The Report] also calls for more updated and consistent 
HIPAA standards. The report points out the healthcare applications increasingly are 
collecting the same sensitive information from patients as doctors’ offices and insurance 
companies through consumer-facing products not covered by HIPAA. . . .  ‘Consumers 
should have transparency and choices over their sensitive health information, regardless 
of who collects it,’ according to the report's authors.”). 
 
125 FTC IoT Report, supra note 102, at vii–viii (emphasis added). 
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[55] Overall, regardless of what law applies, or which regulatory 
agency has the lead, robots will have a significant impact on the data 
protection environment. The health data these increasingly autonomous 
robots will generate, share, and rely on represent a far more complete, and 
therefore sensitive, account of a patient’s health than is found in current 
medical and health records. 
 
VI.  CONCLUSION AND RECOMMENDATIONS 	  
[56] Robots have tremendous potential to have a profoundly positive 
effect on healthcare, both in the hospital and home environments.  
Confronting regulatory challenges involves not only anticipating eventual 
“healthcare companions” or “robotic doctors,” but also understanding the 
characteristics of emerging robots in the coming years.  From a legal 
standpoint, it is important to acknowledge the ways in which robots will 
evolve, including (1) from increasingly autonomous robotic functions of 
medical devices (e.g., autonomous robot surgery), and (2) from increasing 
healthcare functions being performed by general personal robots (e.g., 
Jibo 126  and Pepper 127 ). Current medical device regulation and data 
protection laws will present legal challenges for the emergence of these 
robots that must be addressed in the very near future if innovation is going 
to continue to thrive. Accordingly, this paper has focused on the issues of 
patient and user safety, security, and privacy, and identified gaps in such 
protections that are likely to emerge as robots in healthcare continue to 
advance. 
 
[57] The FDA will regulate many robots as medical devices, including 
increasingly autonomous devices and personal robots that perform certain 
tasks. Because these robots will be subject to premarket review, safety will 
be evaluated before these robots are deployed. However, the FDA’s 
current review is only concerned with device functionality and security as 
they relate to physical safety. Unaccounted for during current premarket 
review are potential non-physical harms that are magnified by autonomous 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
126 See JIBO, supra note 97. 
 
127 See Who is Pepper?, supra note 98. 
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robots in the healthcare setting. Robots in healthcare will present an 
unprecedented expansion and centralization of patient data. HIPAA 
provides some health information disclosure protections of information 
associated with devices after they are already in use, but will not apply to 
certain private consumer robots operating outside of HIPAA’s domain. 
 
[58] As a result, robots warrant an expansion of what is considered 
during premarket review, or through some other similar proactive process.  
Proper design must include taking into consideration these broader 
potential harms that could, if overlooked, manifest themselves in ways that 
harm patients and consumers, diminish the trust of the public in robots, 
and stifle long-term innovation by resulting in overly restrictive 
reactionary regulation.  Because not all robots in healthcare will constitute 
“medical devices,” review might be most appropriately conducted by an 
agency that examines all robots with medical and healthcare-related 
functions.128 
 
[59] Homecare robots may or may not be considered “medical devices,” 
depending on their functions, and may or may not be subject to HIPAA, 
depending on who controls and has access to the robot’s information.  As 
a result, FTC oversight of data practices will be needed in order to better 
protect patient and consumer privacy, especially as robots become more 
prominent in the HIPAA-free zone.  A successful scheme could be one in 
which the FTC oversees a robot’s initial collection of health information, 
while HIPAA continues to govern subsequent disclosure practices.  One 
way to enable such a regulatory scheme is to remove the sector-based 
limitations currently limiting the FTC’s influence in healthcare. 
 
[60] Both pre-deployment review of security and privacy considerations 
and post-deployment enforcement of proper data practices should 
encourage the principles of security and privacy by design. However, 
robotic technology is rapidly advancing and dynamic, so regular review of 
policies and practices by healthcare institutions will also be critical. In 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
128 See, e.g., Ryan Calo, The Case for a Federal Robotics Commission, BROOKINGS INST. 
(Sept. 2014), http://www.brookings.edu/research/reports2/2014/09/case-for-federal-
robotics-commission, archived at https://perma.cc/C4H8-BVZQ. 
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addition, agencies should consider developing emerging technology 
divisions to address these and related issues as automated and robotic 
technologies become ubiquitous. 
 
[61] Because we are likely to see health-related robots appearing in 
both conventional healthcare and consumer spaces, there will be 
regulatory disruption and the opportunity for regulatory arbitrage. We 
argue the regulation of both must change. A foundational regulatory 
framework for both medical devices and data protection that is attuned to 
safety, security, and privacy will help foster innovation and confidence in 
robotics and ensure that we maximize the potential of robots in healthcare. 
